Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
J Infect Dis ; 176(4): 924-32, 1997 Oct.
Article de Anglais | MEDLINE | ID: mdl-9333150

RÉSUMÉ

The role of neutralizing antibodies in human immunodeficiency virus type 1 (HIV-1) infection is poorly understood and was assessed by evaluating responses at different stages of infection. Undiluted sera from long-term nonprogressors (LTNP) had broad neutralizing antibodies against heterologous primary isolates and were more likely to neutralize the contemporaneous autologous isolate than were sera from short-term nonprogressors and progressors. In primary infection, envelope-specific IgG was detected before the initial decline in plasma viremia, but neutralizing antibodies developed more slowly. Here, neutralizing antibodies against strains SF-2 and MN were sometimes the first to be detected, but titers were low for at least 17 weeks from onset of symptoms. Neutralizing antibodies against the early autologous isolate were detected for 4 patients by 5-40 weeks but were undetectable in 2 additional patients for 27-45 weeks. The results indicate that neutralizing antibody responses are slow to develop during primary infection and are uniquely broad in LTNP.


Sujet(s)
Anticorps anti-VIH/analyse , Anticorps anti-VIH/immunologie , Infections à VIH/immunologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/immunologie , Tests de neutralisation , Numération des lymphocytes CD4 , Cellules cultivées , Chimiokine CCL4 , Chimiokine CCL5/analyse , Chimiokine CCL5/immunologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/croissance et développement , Humains , Immunoglobuline G/analyse , Immunoglobuline G/immunologie , Agranulocytes , Protéines inflammatoires des macrophages/analyse , Protéines inflammatoires des macrophages/immunologie , Survivants , Charge virale , Virémie/immunologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...